Home > Pressrelease > U.S. Clinical Nutrition Market size to exceed $23Bn by 2030

U.S. Clinical Nutrition Market size to exceed $23Bn by 2030

  • Published Date: November 4, 2022

U.S. Clinical Nutrition Market size is projected to reach USD 23 billion by 2030, as per the latest report published by Global Market Insights Inc.

Rapid rise in preterm birth rates will augment the need for clinical nutrition and dietetics in the U.S. Clinical nutrition is playing a pivotal role in the treatment of health conditions that affect dietary constituent intake, metabolism, and absorption, including preterm birth. Based on data from the March of Dimes Organization, over 380,000 babies are born prematurely in the country per year. Furthermore, the burden of chronic diseases among newborns has risen, contributing to the expansion of clinical nutrition centers in the region.

Preference for parenteral feeding to drive clinical nutrition products demand

U.S. clinical nutrition market from parenteral segment was worth over USD 1 billion in 2021. The rapidly aging population and the rising birth rates are among the key factors proliferating the use of parenteral nourishment in the U.S. Since electrolytes, amino acids, lipid emulsions, and trace elements are among the crucial components, parenteral feeding is recommended for premature babies, infants, and even the elderly. These benefits will improve the consumption of parenteral feeding products to help patients meet their nutritional requirements.

High burden of malnourishment to drive clinical supplement consumption among adults

U.S. clinical nutrition market from the adult segment was valued at more than USD 4.5 billion in 2021, considering the high prevalence of malnutrition. The report reveals that malnourishment is a major concern among older adults. Given the associated risks of cardiac nutritional imbalance and liver and renal problems, among other complications, malnourished adults are increasingly opting for products such as nutritional supplements. Malnutrition among hospitalized patients is also emerging as a serious healthcare issue, thus contributing to the expansion of clinical nutrition health centers in the U.S.

Browse key industry insights spread across 89 pages with 51 market data tables & 16 figures & charts from the report, “U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

Prevalence of GI disorder-associated malnutrition augments clinical nutrition product use

Gastrointestinal disorders segment will be more than USD 6 billion by 2030, owing to the risk of undernourishment in patients experiencing the illness. With the growing population, malnutrition has become a prominent health concern among pediatrics and adult populations. This can lead to gastrointestinal diseases including bloating, abdominal discomfort, excessive infusion rate, and constipation. The shortfall in protein and calories has also become more common in patients with chronic GI disorders, augmenting the requirement for clinical nutrition supplements.

Growing focus on product reliability expands sales volumes from pharmacies & drug stores

Pharmacies & drug stores segment held over 27% share of the U.S. clinical nutrition market in 2021, owing to a high consumer preference for quality clinical nutrition solutions. Nutritional products available through drug stores and pharmacies are affordable, authentic, and reliable, making them a preferred sales channel among consumers. Furthermore, with the rise in employment of pharmacists across the United States, the sales of clinical nutrition solutions through drug stores will increase, the report claims.

Product range certification efforts to remain a key growth strategy for industry players

Prominent players in U.S. clinical nutrition industry include Mead Johnson (Reckitt Benckiser), Baxter International Inc., Fresenius Kabi, B Braun Melsungen AG, Nestle Health Science, Hero Nutritionals Inc., Pfizer, Inc., and Danone, among others. These companies are implementing strategies such as product range expansion and certifications to boost their presence in the regional industry.

Authors: Sumant Ugalmugle, Rupali Swain